Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Regulatory T cells are essential for normal and improved wound healing in mice.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

The study suggests that hypothyroidism may cause alopecia areata.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Fzd2 is important for skin and hair development through various signaling ways.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Ustekinumab helped three kids with alopecia areata regrow hair.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.